Portfolio company
Curis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops drug candidates for the treatment of various cancers and hematologic malignancies for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mersana Therapeutics
This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.
C4 Therapeutics
This biopharmaceutical company develops small-molecule medicines that degrade disease-causing proteins to treat cancer and other difficult diseases for patients and healthcare providers.
Akanocure Pharmaceuticals
This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.
CytomX
This biopharmaceutical company develops conditionally activated antibody therapeutics for oncology patients and healthcare providers.
Calithera
This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
CuroTis
This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
